Stocks · Healthcare · Medical - Care Facilities

Brookdale Senior Living Inc. BKD

$10.86 +0.18% Close, Oct 2, 2026 · NYSE · Market cap $2.59B

Inexpensive vs sectorLow risk

Next earnings report: Nov 5, 2026

Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.

Three things to know

  1. The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
  2. The stock is 35% below its highest close of the past year.
  3. Revenue over the last four quarters was $3.02B, down 2.3% from a year earlier, slowing from 3.1% a quarter earlier.

PromtFinance scores

Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.

Growth28Very weak

How fast revenue, earnings and cash flow are growing.

  • Revenue growth (TTM, YoY)Bottom 27%
  • FCF growth (TTM, YoY)Top 35%
  • Revenue growth, 3-year CAGRBottom 36%
  • Revenue growth accelerationBottom 24%
Quality60Neutral

Returns on capital, margins, earnings quality and balance-sheet strength.

  • Return on invested capitalTop 29%
  • Gross marginBottom 12%
  • Operating marginTop 36%
  • Accruals (lower is better)Bottom 48%
  • Net debt / EBITDA (lower is better)Top 47%
  • Interest coverTop 42%
Value87Strong

How cheap the shares are relative to earnings, cash flow and their own history.

  • Earnings yieldTop 44%
  • Free-cash-flow yieldTop 33%
  • EBITDA / enterprise valueTop 2%
  • Sales / enterprise valueTop 12%
Momentum37Weak

Strength and persistence of the price trend, including versus the S&P 500.

  • 12-month return excluding last monthTop 38%
  • 6-month returnBottom 22%
  • 1-year return vs S&P 500Top 39%
  • Distance from 52-week highBottom 44%
  • Trend checklist (0–4)Bottom 14%
Revisions16Very weak

Earnings surprises and analyst sentiment (estimate-revision history is being collected).

  • Average EPS surprise, last 4 quartersBottom 17%
  • Consecutive EPS beatsBottom 49%
  • Share of analysts rating BuyBottom 23%
  • Upside to consensus price targetTop 46%
Stability93Exceptional

Low volatility, shallow drawdowns, low market sensitivity and modest leverage.

  • Volatility, 60 days (lower is better)Top 17%
  • Maximum drawdown, 3 yearsTop 17%
  • Beta vs S&P 500 (lower is better)Top 2%
  • Net debt / EBITDA (lower is better)Top 47%

What changed

Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).

MeasureBeforeNow
Revenue growth (YoY)3.1%-2.3%↓
Gross margin27.1%14.4%↓
Operating margin1.7%3.8%↑
FCF margin0.6%0.8%↑

Fundamental momentum

MeasureNow (TTM)Year / quarter beforeSector rank
Revenue growth (TTM, YoY)-2.3%3.1%↓Bottom 27%
Gross margin14.4%27.1%↓Bottom 12%
Operating margin3.8%1.7%↑Top 36%
Net margin-4.6%-7.9%↑—
Free-cash-flow margin0.8%0.6%↑—
Return on invested capital2.0%—Top 29%
Revenue growth, 3-year CAGR4.4%—Bottom 36%

Quality of earnings and balance sheet

Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
-6.1%
Stock-based compensation / revenueA cost to shareholders through dilution.
0.4%
Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
+3.0 pp
Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
1.04×
Interest cover (operating income / interest)How many times operating profit covers interest.
0.6×

Shareholder returns

Dividend yield (dividends paid, TTM)
0.00%
Net buyback yield (TTM)
0.07%
Shareholder yield
0.07%
Share count change, 1 year
+4.8%
Share count change, 3-year CAGR
+2.7%

Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.

Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).

Earnings and expectations

Earnings momentum

Consecutive EPS beats
1
Beats in the last 8 reports
1 of 8
Average EPS surprise, last 4
-31.5%
Average 2-day reaction, last 8
-2.0%
Positive 20 days after report
2 of 8

Analysts

Consensus price target
$19.00
Target vs current price
+75.0%
Analysts with a rating
12
Share rating Buy or Strong Buy
58%
Consensus rating
Buy

How the stock reacted to recent reports

Report dateEPS surprise2 days5 days20 days60 days
Aug 10, 2026+280.2%-3.7%-11.1%-17.2%—
May 6, 2026-200.0%+1.1%-7.5%-12.7%+4.1%
Feb 18, 2026-6.3%-0.5%-7.7%-12.6%-22.7%
Nov 6, 2025-200.0%-1.7%+13.4%+14.8%+70.9%
Aug 6, 2025-28.6%-1.0%-8.2%-3.2%+13.6%
May 6, 2025-154.5%+1.8%+3.2%-0.5%+16.9%
Feb 18, 2025-131.3%-0.2%+6.2%+15.8%+30.3%
Nov 7, 2024-29.4%-11.8%-15.8%-13.3%-27.4%

Returns from the close before each report. Past reactions do not determine future ones.

Earnings history

Report dateEPSEstimateSurpriseRevenue
Aug 10, 2026$0.10-$0.06+280.2%$718.6M
May 6, 2026-$0.03$0.03-200.0%$764.9M
Feb 18, 2026-$0.17-$0.16-6.3%$754.1M
Nov 6, 2025-$0.48-$0.16-200.0%$813.2M
Aug 6, 2025-$0.18-$0.14-28.6%$812.9M
May 6, 2025-$0.28-$0.11-154.5%$813.9M
Feb 18, 2025-$0.37-$0.16-131.3%$780.9M
Nov 7, 2024-$0.22-$0.17-29.4%$784.2M

Valuation in context

MultipleNow5-year median5-year percentileSector rank (cheapness)
P/E (forward)325.8×———
EV / EBITDA4.0×——Top 2%
EV / Sales1.16×——Top 12%
Free-cash-flow yield0.91%——Top 33%
Earnings yield-5.33%——Top 44%

Technical state

Trend checklist

  • ✗ Price above 20-day average
  • ✗ Price above 50-day average
  • ✗ Price above 200-day average
  • ✗ 50-day average above 200-day
  • ✗ MACD histogram positive

Trend quality

Days above the 50-day average
0
Days above the 200-day average
0
50-day average slope (20 days)
-10.5%
200-day average slope (20 days)
+0.6%
Distance from 50-day average
-12.9%
Distance from 200-day average
-18.9%
RSI (14)
24.7
Relative volume
1.61×

Risk and drawdowns

Volatility, 60 days (annualized)
35.9%
Volatility vs own 5-year history
15th percentile · Low for this stock
Beta vs S&P 500 (2 years, weekly)
-0.08
Correlation with S&P 500
-0.03
Current drawdown from 1-year high
-35.2%
Maximum drawdown, 3 years
-43.6%

Largest declines in the past six years

From peakTo lowDeclineLengthRecovery
Jun 16, 2021Mar 23, 2023-73.1%445 days639 days (Oct 9, 2025)
Feb 11, 2026Sep 30, 2026-35.4%159 daysNot yet recovered
Oct 23, 2020Nov 5, 2020-20.3%9 days2 days (Nov 9, 2020)
Mar 15, 2021Mar 24, 2021-17.2%7 days10 days (Apr 8, 2021)
Nov 24, 2020Dec 11, 2020-15.8%12 days21 days (Jan 13, 2021)

Declines of 10% or more from a closing high, measured on daily closes.

Financial statements

Market cap
$2.59B
EPS, diluted (TTM)
-$0.58
Revenue (TTM)
$3.02B
52-week range
$7.97 – $17.09
FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$2.75B$2.74B$2.87B$2.98B$3.12B
Gross profit$488.6M$513.9M$744.7M$807.4M$645.0M
Operating income-$216.9M-$42.7M$18.4M$46.5M$17.2M
Net income-$99.3M-$238.4M-$189.0M-$201.9M-$262.7M
EPS (diluted)-$0.54-$1.25-$0.84-$0.89-$1.11
Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Revenue$746.4M$747.0M$780.1M$812.9M$777.8M$754.1M$764.9M$718.6M
Net income-$50.7M-$83.9M-$65.0M-$43.0M-$114.7M-$40.0M-$6.9M$23.3M
EPS (diluted)-$0.22-$0.37-$0.28-$0.18-$0.48-$0.17-$0.03$0.10
FY 2021FY 2022FY 2023FY 2024FY 2025
Operating cash flow-$94.6M$3.3M$162.9M$166.2M$218.0M
Capital expenditure-$176.7M-$196.9M-$233.2M-$200.6M-$201.5M
Free cash flow-$271.3M-$193.6M-$70.3M-$34.4M$16.5M
Dividends paid$0$0$0$0$0
Net share buybacks-$4.8M$139.4M-$1.9M-$3.4M-$6.5M

Cash outflows are shown as negative numbers.

Cash and short-term investments
$390.3M
Total assets
$5.90B
Total liabilities
$5.93B
Total debt
$1.29B
Net debt
$918.8M
Shareholders’ equity
-$29.0M

As of Jun 30, 2026 (filed Aug 10, 2026).

Dividends

Ex-dateAmountPaid
Oct 8, 2008$0.25Oct 17, 2008
Jul 2, 2008$0.25Jul 15, 2008
Mar 27, 2008$0.25Apr 14, 2008
Dec 27, 2007$0.50Jan 14, 2008
Sep 26, 2007$0.50Oct 12, 2007
Jun 27, 2007$0.50Jul 13, 2007
Mar 28, 2007$0.45Apr 13, 2007
Dec 27, 2006$0.45Jan 15, 2007

Short interest

Shares sold short
45,328,780
Days to cover
10.18
Change vs previous report
+11.2%

FINRA short interest, settlement date Sep 15, 2026.

Stock splits

Apr 8, 2015
5-for-6